Log In
Print this Print this

Stapled peptide

  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionNOTCH1 inhibitor
Molecular Target Notch 1 (NOTCH1)
Mechanism of ActionNotch inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsTreat acute lymphoblastic leukemia (ALL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today